EGFR and non-small cell lung carcinoma: (11) Song et al. used machine learning to identify patients with non-small cell lung cancer who would not benefit from epidermal growth factor receptor tyrosine kinase inhibitor therapy (EGFR-TKI therapy) (12), and the results provided the important guidelines for clinical practices in patients with non-small cell lung cancer.